{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:20:46Z","timestamp":1788956446675,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.euroneuro.2012.02.002","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T08:33:56Z","timestamp":1331282036000},"page":"695-703","source":"Crossref","is-referenced-by-count":49,"title":["Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients"],"prefix":"10.1016","volume":"22","author":[{"given":"Sheng-Chang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Hui","family":"Tsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ing-Kang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Fu","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Yuan","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Chi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Liang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien-Wen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Lun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keh-Ming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu Chih","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Wei","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Chen","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ni","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2012.02.002_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pain.2005.11.005","article-title":"Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations","volume":"120","author":"Athanasos","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300598","article-title":"Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden","volume":"30","author":"Bart","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0020","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","article-title":"Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction","volume":"95","author":"Bond","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0030","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/clpt.2010.127","article-title":"OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths","volume":"88","author":"Bunten","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1369-1600.2010.00274.x","article-title":"CYP2B6 and OPRM1 gene variations predict methadone-related deaths","volume":"16","author":"Bunten","year":"2011","journal-title":"Addict. Biol."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ajmg.b.20057","article-title":"Association between human mu-opioid receptor gene polymorphism, pain tolerance, and opioid addiction","volume":"121B","author":"Compton","year":"2003","journal-title":"Am. J. Med. Genet. B."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0040","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.pnpbp.2008.07.009","article-title":"Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment","volume":"32","author":"Crettol","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1369-1600.2010.00265.x","article-title":"A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women","volume":"17","author":"Crystal","year":"2012","journal-title":"Addict. Biol."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0050","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1471-4159.2009.06472.x","article-title":"Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction","volume":"112","author":"Deb","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0055","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/j.1360-0443.2005.01232.x","article-title":"Methadone doses of 100mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers","volume":"100","author":"Donny","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jpain.2004.11.008","article-title":"The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans","volume":"6","author":"Fillingim","year":"2005","journal-title":"J. Pain"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF03256370","article-title":"Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes","volume":"14","author":"Fonseca","year":"2010","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1096-8628(20010108)105:1<114::AID-AJMG1074>3.0.CO;2-L","article-title":"Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence","volume":"105","author":"Franke","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/00952997709002743","article-title":"Adequacy of sexual performance in men maintained on methadone","volume":"4","author":"Hanbury","year":"1977","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2105\/AJPH.85.1.83","article-title":"Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use","volume":"85","author":"Hartel","year":"1995","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0085","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2217\/14622416.9.11.1605","article-title":"Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype","volume":"9","author":"Hayashida","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0090","doi-asserted-by":"crossref","first-page":"R1599","DOI":"10.1152\/ajpregu.00020.2008","article-title":"Inhibitory and excitatory effects of micro-, delta-, and kappa-opioid receptor activation on breathing in awake turtles, Trachemys scripta","volume":"295","author":"Johnson","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0095","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1399-6576.2004.00517.x","article-title":"The 118 A>G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease","volume":"48","author":"Klepstad","year":"2004","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0100","first-page":"232","article-title":"Opiates, opioids and addiction","volume":"1","author":"Kreek","year":"1996","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/10550880903014155","article-title":"Insomnia among methadone-maintained individuals: the feasibility of collecting home polysomnographic recordings","volume":"28","author":"Kurth","year":"2009","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molmed.2004.12.006","article-title":"Are mu-opioid receptor polymorphisms important for clinical opioid therapy?","volume":"11","author":"Lotsch","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0115","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.tpj.6500362","article-title":"Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers","volume":"6","author":"Lotsch","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0120","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/j.1360-0443.2008.02284.x","article-title":"Development of the treatment outcomes profile","volume":"103","author":"Marsden","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/syn.20355","article-title":"Differential regional effects of methadone maintenance compared to heroin dependence on \u00a3g-opioid receptor desensitization in rat brain","volume":"61","author":"Martin","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0130","first-page":"1","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(00)00099-1","article-title":"Regulations of opioid dependence by opioid receptor types","volume":"89","author":"Narita","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000093099","article-title":"Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population","volume":"53","author":"Nishizawa","year":"2006","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0145","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1074\/jbc.M807030200","article-title":"A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain","volume":"284","author":"Oertel","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1530-0277.2008.00846.x","article-title":"OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach","volume":"33","author":"Oroszi","year":"2009","journal-title":"Alcoholism (NY)"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0155","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1073\/pnas.0811586106","article-title":"Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions","volume":"106","author":"Pan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0160","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00213-006-0504-2","article-title":"Association of OPRM1 A118G variant with the relative reinforcing value of nicotine","volume":"188","author":"Ray","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0165","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2144\/jun0204","article-title":"A strategy for the rapid discovery of disease markers using the MassARRAY system","volume":"32","author":"Rodi","year":"2002","journal-title":"Biotechniques"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0169-328X(98)00051-5","article-title":"mu-Opioid receptor-knockout mice: the role of mu-opioid receptor in gastrointestinal transit","volume":"56","author":"Roy","year":"1998","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0175","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/hmg\/ddn439","article-title":"Expansion of the human mu-opioid receptor gene architecture: novel functional variants","volume":"18","author":"Shabalina","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.drugalcdep.2010.08.007","article-title":"Assessing sleep in opioid dependence: a comparison of subjective ratings, sleep diaries, and home polysomnography in methadone maintenance patients","volume":"113","author":"Sharkey","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0185","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/humu.9026","article-title":"Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin","volume":"19","author":"Shi","year":"2002","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0190","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1214\/aos\/1074290335","article-title":"The positive false discovery rate: a Bayesian interpretation and the q-value","volume":"31","author":"Storey","year":"2003","journal-title":"Ann. Stat."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0195","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.clinbiochem.2004.12.005","article-title":"Genotyping single nucleotide polymorphisms by MALDI mass spectrometry in clinical applications","volume":"38","author":"Tost","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.drugalcdep.2009.07.022","article-title":"Effects of sleep deprivation on sleep homeostasis and restoration during methadone-maintenance: a [31]P MRS brain imaging study","volume":"106","author":"Trksak","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0205","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pain.2009.07.013","article-title":"Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment","volume":"146","author":"Walter","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0210","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/bmc.1363","article-title":"Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients","volume":"24","author":"Wang","year":"2010","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0215","doi-asserted-by":"crossref","first-page":"15079","DOI":"10.1073\/pnas.0812612106","article-title":"Variation in the mu-opioidreceptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection","volume":"106","author":"Way","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0220","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The Clinical Opiate Withdrawal Scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0225","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/clinchem\/37.2.205","article-title":"Methadone concentrations in plasma and their relationship to drug dosage","volume":"37","author":"Wolff","year":"1991","journal-title":"Clin. Chem."},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0230","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1208\/ps040423","article-title":"Bioinformatic analysis of the human mu opioid receptor (OPRM1) splice and polymorphic variants","volume":"4","author":"Xin","year":"2002","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.euroneuro.2012.02.002_bb0235","doi-asserted-by":"crossref","first-page":"W635","DOI":"10.1093\/nar\/gkl236","article-title":"FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization","volume":"34","author":"Yuan","year":"2006","journal-title":"Nucleic Acids Res."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1200048X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1200048X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T23:49:47Z","timestamp":1593820187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X1200048X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0924977X1200048X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.02.002","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}